Efficacy and Safety of a Pharmaco-Invasive Strategy With Half-Dose Alteplase Versus Primary Angioplasty in ST-Segment–Elevation Myocardial Infarction

医学 心肌梗塞 经皮冠状动脉介入治疗 心脏病学 传统PCI 内科学 射血分数 临床终点 纤溶 血管成形术 ST段 心导管术 纤溶剂 溶栓 随机对照试验 蒂米 心力衰竭 组织纤溶酶原激活剂
作者
Jun Pu,Song Ding,Heng Ge,Yaling Han,Guo Jin-chen,Rong Lin,Xi Su,Heng Zhang,Lianglong Chen,Ben He
出处
期刊:Circulation [Lippincott Williams & Wilkins]
卷期号:136 (16): 1462-1473 被引量:92
标识
DOI:10.1161/circulationaha.117.030582
摘要

Timely primary percutaneous coronary intervention (PPCI) cannot be offered to all patients with ST-segment-elevation myocardial infarction (STEMI). Pharmaco-invasive (PhI) strategy has been proposed as a valuable alternative for eligible patients with STEMI. We conducted a randomized study to compare the efficacy and safety of a PhI strategy with half-dose fibrinolytic regimen versus PPCI in patients with STEMI.The EARLY-MYO trial (Early Routine Catheterization After Alteplase Fibrinolysis Versus Primary PCI in Acute ST-Segment-Elevation Myocardial Infarction) was an investigator-initiated, prospective, multicenter, randomized, noninferiority trial comparing a PhI strategy with half-dose alteplase versus PPCI in patients with STEMI 18 to 75 years of age presenting ≤6 hours after symptom onset but with an expected PCI-related delay. The primary end point of the study was complete epicardial and myocardial reperfusion after PCI, defined as thrombolysis in myocardial infarction flow grade 3, thrombolysis in myocardial infarction myocardial perfusion grade 3, and ST-segment resolution ≥70%. We also measured infarct size and left ventricular ejection fraction with cardiac magnetic resonance and recorded 30-day clinical and safety outcomes.A total of 344 patients from 7 centers were randomized to PhI (n=171) or PPCI (n=173). PhI was noninferior (and even superior) to PPCI for the primary end point (34.2% versus 22.8%, Pnoninferiority<0.05, Psuperiority=0.022), with no significant differences in the frequency of the individual components of the combined end point: thrombolysis in myocardial infarction flow 3 (91.3% versus 89.2%, P=0.580), thrombolysis in myocardial infarction myocardial perfusion grade 3 (65.8% versus 62.9%, P=0.730), and ST-segment resolution ≥70% (50.9% versus 45.5%, P=0.377). Infarct size (23.3%±11.3% versus 25.8%±13.7%, P=0.101) and left ventricular ejection fraction (52.2%±11.0% versus 51.4%±12.0%, P=0.562) were similar in both groups. No significant differences occurred in 30-day rates of total death (0.6% versus 1.2%, P=1.0), reinfarction (0.6% versus 0.6%, P=1.0), heart failure (13.5% versus 16.2%, P=0.545), major bleeding events (0.6% versus 0%, P=0.497), or intracranial hemorrhage (0% versus 0%), but minor bleeding (26.9% versus 11.0%, P<0.001) was observed more often in the PhI group.For patients with STEMI presenting ≤6 hours after symptom onset and with an expected PCI-related delay, a PhI strategy with half-dose alteplase and timely PCI offers more complete epicardial and myocardial reperfusion when compared with PPCI. Adequately powered trials with this reperfusion strategy to assess clinical and safety outcomes are warranted.URL: https://www.clinicaltrials.gov. Unique identifier: NCT01930682.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
橙色小人发布了新的文献求助10
1秒前
cyan发布了新的文献求助30
3秒前
4秒前
天天快乐应助喜喵喵采纳,获得10
4秒前
shinysparrow应助dream采纳,获得200
4秒前
6秒前
KevenDing完成签到,获得积分10
8秒前
wulalala发布了新的文献求助30
9秒前
CipherSage应助loski采纳,获得10
9秒前
我是老大应助loski采纳,获得10
9秒前
完美世界应助loski采纳,获得10
10秒前
李健应助loski采纳,获得10
10秒前
欣喜沛芹发布了新的文献求助10
12秒前
可爱的函函应助橙色小人采纳,获得10
13秒前
ED应助多发论文采纳,获得10
15秒前
15秒前
量子星尘发布了新的文献求助10
15秒前
Owen应助机智思真采纳,获得10
16秒前
传奇3应助loski采纳,获得10
17秒前
万能图书馆应助自觉的凛采纳,获得10
19秒前
23秒前
积极幻桃应助ssjjzhou采纳,获得10
24秒前
讨厌科研完成签到,获得积分10
25秒前
28秒前
Xw发布了新的文献求助10
30秒前
31秒前
失眠的霸完成签到,获得积分10
32秒前
ChatGPT发布了新的文献求助10
33秒前
35秒前
多发论文完成签到,获得积分20
36秒前
36秒前
37秒前
su发布了新的文献求助10
37秒前
Xw关闭了Xw文献求助
37秒前
大个应助fjm采纳,获得10
40秒前
而为发布了新的文献求助30
40秒前
机智思真发布了新的文献求助10
40秒前
木樨316完成签到,获得积分10
40秒前
43秒前
花花完成签到 ,获得积分10
45秒前
高分求助中
A new approach to the extrapolation of accelerated life test data 1000
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
‘Unruly’ Children: Historical Fieldnotes and Learning Morality in a Taiwan Village (New Departures in Anthropology) 400
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
基于可调谐半导体激光吸收光谱技术泄漏气体检测系统的研究 350
Robot-supported joining of reinforcement textiles with one-sided sewing heads 320
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3989378
求助须知:如何正确求助?哪些是违规求助? 3531442
关于积分的说明 11254002
捐赠科研通 3270126
什么是DOI,文献DOI怎么找? 1804887
邀请新用户注册赠送积分活动 882087
科研通“疑难数据库(出版商)”最低求助积分说明 809173